LYFGENIA - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Representative image of MS Dhoni in an IPL-style cricket setting, used for illustrative purposes alongside coverage of Chennai Super Kings’ early 2026 injury setback.

MS Dhoni ruled out of first two weeks of IPL 2026 with calf strain, CSK face early squad crisis

Denver Nuggets surge into the 2026 NBA playoffs with Jokic and Murray in historic form

Representative image of a United States Navy unmanned surface vessel operating near a naval warship, illustrating the US Navy’s MASC programme cancellation and the launch of the $2.1 billion MUSV marketplace under the Golden Fleet strategy.

US Navy cancels MASC programme, launches $2.1bn MUSV marketplace as the Golden Fleet strategy moves from concept to procurement

No Kings protests return to New York City for third time as nationwide mobilisation targets Trump administration policies

bluebird bio reveals US commercial strategy for LYFGENIA gene therapy

Read More

2 minute read

Pharma Industry News

bluebird bio unveils US commercial strategy for LYFGENIA gene therapy

bluebird bio, Inc., a pioneer in the biotechnology industry, has announced the U.S. commercial infrastructure for LYFGENIA (lovotibeglogene…

byPallavi Madhiraju

December 9, 2023

web analytics